Ildong Pharmaceutical challenges to KRW 100 billion market of filler
Ildong Pharmaceutical(CEO Woong-Sup Yoon) released ‘Neobelle,’ hyaluronic acid filler for wrinkle improvement, and has started to pioneer its market. Based on the original technology, infrastructure and sales & marketing power related to hyaluronic acid, the company plans to make Neobelle a leadi...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.